DIMS Lectures Respiratory Pathology PDF
Kindly scroll down for the complete pdf lecture of respiratory pathology ,


Summary
1. Obstructive Lung Diseases
Obstructive lung diseases are characterized by airway obstruction leading to difficulty in exhalation.
A. Chronic Obstructive Pulmonary Disease (COPD)
COPD is a progressive and irreversible lung disease caused by long-term exposure to irritants like smoking and pollution.
Pathophysiology:
Chronic inflammation leads to narrowing of airways.
Mucus hypersecretion causes bronchial obstruction.
Destruction of alveoli leads to reduced gas exchange.
Key Features:
Chronic cough with sputum production.
Dyspnea (shortness of breath).
Prolonged expiration with wheezing.
Clinical Correlation:
Spirometry shows decreased FEV1/FVC ratio.
Patients present with barrel chest due to air trapping.
B. Asthma
Asthma is a chronic inflammatory disease that causes episodic airway constriction.
Pathophysiology:
Bronchial hyperreactivity leads to airway narrowing.
Histamine release triggers bronchospasm.
Mucosal edema and mucus plugging exacerbate obstruction.
Symptoms:
Intermittent wheezing.
Shortness of breath, often triggered by allergens or exercise.
Cough, particularly at night.
Clinical Correlation:
Reversible airway obstruction on spirometry.
Increased eosinophils in sputum.
2. Restrictive Lung Diseases
Restrictive lung diseases limit lung expansion, reducing lung volume and compliance.
Pulmonary Fibrosis
A chronic interstitial lung disease leading to fibrosis and scarring of lung tissue.
Pathophysiology:
Excess collagen deposition in lung interstitium.
Thickened alveolar walls impair gas exchange.
Symptoms:
Progressive dyspnea.
Dry cough.
Clubbing of fingers.
Clinical Correlation:
Decreased TLC and FVC on lung function tests.
Honeycombing pattern on HRCT scan.
3. Pulmonary Embolism (PE)
A life-threatening condition where a blood clot blocks a pulmonary artery.
Pathophysiology:
Deep vein thrombosis (DVT) dislodges and travels to the lungs.
Obstructed pulmonary circulation leads to hypoxia.
Symptoms:
Sudden onset dyspnea.
Pleuritic chest pain.
Hemoptysis (coughing up blood).
Clinical Correlation:
D-dimer test is elevated.
CT pulmonary angiography (CTPA) confirms diagnosis.
4. Respiratory Failure
Respiratory failure occurs when the lungs fail to oxygenate blood or remove CO₂ effectively.
Types of Respiratory Failure:
1. Type 1 (Hypoxemic) – Low oxygen, normal CO₂ (e.g., ARDS).
2. Type 2 (Hypercapnic) – High CO₂, normal or low oxygen (e.g., COPD).
Symptoms:
Cyanosis (bluish skin).
Altered mental status.
Tachypnea or bradypnea (rapid or slow breathing).
Clinical Correlation:
Arterial Blood Gas (ABG) analysis shows low PaO₂ and/or high PaCO₂.
5. Tuberculosis (TB)
A chronic bacterial infection caused by Mycobacterium tuberculosis.
Pathophysiology:
Bacteria infect the lungs and form granulomas.
The Ghon complex is seen in primary TB.
Symptoms:
Chronic cough lasting more than 3 weeks.
Night sweats and fever.
Weight loss.
Clinical Correlation:
Positive Mantoux (PPD) test.
Cavitary lesions on chest X-ray.
6. COVID-19 and Respiratory Complications
COVID-19 primarily affects the lungs, causing severe pneumonia in critical cases.
Pathophysiology:
Viral invasion leads to alveolar damage.
Cytokine storm causes massive lung inflammation.
Symptoms:
Persistent fever.
Shortness of breath.
Loss of taste and smell.
Clinical Correlation:
Ground-glass opacities on CT scan.
Hypoxia requiring oxygen therapy.
7. Prevention and Management of Respiratory Diseases
A. General Preventive Measures
1. Quit smoking – Prevents COPD and lung cancer.
2. Vaccinations – Influenza and pneumococcal vaccines.
3. Pollution control – Reduces asthma triggers.
4. Regular exercise – Improves lung capacity.
B. Medical Treatment Approaches
Bronchodilators for COPD and asthma.
Antibiotics for pneumonia and TB.
Anticoagulants for pulmonary embolism.
Oxygen therapy for severe respiratory failure.
Comments
Post a Comment